Guru Ownership Trend
Guru Analysis for Trevi Therapeutics, Inc. (TRVI)
Trevi Therapeutics, Inc. (TRVI), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $51.3 M.
Top institutional holders include Andreas Halvorsen and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $25.44 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Andreas Halvorsen reduced exposure by 37.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Trevi Therapeutics, Inc. (TRVI)
Major holders include Andreas Halvorsen ($40.05 M), Steven Cohen ($12.52 M), Paul Tudor Jones ($857,382). According to the latest reported data, 4 tracked investment managers collectively hold approximately 4.3 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $25.44 M, with 2 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited TRVI. The total reported sell value was $27.02 M.
Yes, 1 managers opened new positions in TRVI, and 1 increased their existing holdings. The total reported buy value was $1.58 M.